AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glinist M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Venistro Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glinist M 1mg/500mg Tablet SR

Glinist M 1mg/500mg extended-release tablets are classified as antidiabetic agents. This dual-medication formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glinist M 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glinist M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glinist M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Glinist M 1mg/500mg sustained-release tablet with food.

Common Side effects of Glinist M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glinist M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glinist M 1mg/500mg SR Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.

How Glinist M 1mg/500mg Tablet SR works:

Glinist M SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glinist M 1mg/500mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glinist M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glinist M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glinist M 1mg/500mg SR tablets, as dose modification may be necessary. Consult your physician for guidance. Glinist M 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Glinist M 1mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. For patients experiencing mild to moderate liver dysfunction, initiate Glinist M 1mg/500mg Tablet SR therapy at a reduced dosage; however, it's contraindicated in those with severe liver disease.

What if you forget to take Glinist M 1mg/500mg Tablet SR :

Should you forget a Glinist M 1mg/500mg SR tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glinist M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glinist M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glinist M 1mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glinist M 1mg/500mg Tablet SR and seek immediate medical attention.
Glinist M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glinist M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glinist M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glinist M 1mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glinist M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glinist M 1mg/500mg Table...
47
MRP 55
14% off